B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Clinical trials for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) explained in plain language.
Never miss a new study
Get alerted when new B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) trials appear
Sign up with your email to follow new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough leukemia: experimental drug AZD4512 enters human trials
Disease control Recruiting nowThis study is testing an experimental drug called AZD4512, given alone or with other cancer medicines, in people whose B-cell acute lymphoblastic leukemia (B-ALL) has returned or stopped responding to standard treatments. The main goals are to check the drug's safety and find the…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New hope for kids with tough leukemia: smarter CAR T-Cell production under study
Disease control Recruiting nowThis study is for children with B-cell acute lymphoblastic leukemia (B-ALL) that has come back or not responded to treatment. Researchers are testing a new way to make special immune cells, called CAR T-cells, using a machine called CliniMACS Prodigy. The goal is to see if this n…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: PHASE1, PHASE2 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New hope for tough leukemia: experimental drug AZD0486 enters human trials
Disease control Recruiting nowThis study tests an experimental drug called AZD0486 in teenagers and adults with B-cell acute lymphoblastic leukemia (B-ALL) that has returned or not responded to at least two prior treatments. The goal is to see if the drug is safe and can shrink or eliminate cancer cells. Part…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC
-
CAR T-Cell survivors: what happens years later?
Knowledge-focused Recruiting nowThis study looks at the long-term health and quality of life of children and young adults who received CAR T-cell therapy for B-cell acute lymphoblastic leukemia. Researchers will track participants for at least two years after treatment to understand late side effects, brain fun…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC